Clinical trial
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
NCT00000274 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00000274 |
|---|---|
| Title | Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9 |
| Official title | Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | New York State Psychiatric Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders, Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | Flupenthixol |
| Enrollment | 60 |
| Start date | Mar 1, 1997 |
| Completion | May 1, 1999 |
| First posted | Sep 21, 1999 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: